Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

     
[X]   Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    For the period ended November 30, 2003.
     
[  ]   Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    For the transition period from ___________________ to ___________________
     
    Commission File Number 1-9927

COMPREHENSIVE CARE CORPORATION

(Exact name of registrant as specified in its charter)
     
Delaware   95-2594724

 
(State or other jurisdiction of incorporation
or organization)
  (IRS Employer Identification No.)

200 South Hoover Blvd, Suite 200, Tampa, FL 33609


(Address of principal executive offices and zip code)

(813) 288-4808


(Registrant’s telephone number, including area code)

      Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [  ]

      Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ] No [X]

      Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the latest practicable date:

     
Classes   Outstanding at January 5, 2004

 
Common Stock, par value $.01 per share   4,643,049

 


TABLE OF CONTENTS

PART I. — FINANCIAL INFORMATION
Item 1 — Consolidated Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Operations
Consolidated Statements of Cash Flows
Item 2 — Management’s discussion and analysis of financial condition and Results of operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II — OTHER INFORMATION
Item 1 — LEGAL PROCEEDINGS
Item 2 — CHANGES IN SECURITIES AND USE OF PROCEEDS
Item 6 — Exhibits and Reports on Form 8-K
SIGNATURES
EX-31.1 Section 302 Certification of CEO
EX-31.2 Section 302 Certification of CFO
EX-32.1 Section 906 Certification of CEO
EX-32.2 Section 906 Certification of CFO


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Index

             
        Page
PART I – FINANCIAL INFORMATION
       
 
Item 1—Consolidated Financial Statements
       
   
Consolidated Balance Sheets, November 30, 2003 and May 31, 2003
    3  
   
Consolidated Statements of Operations for the Three and Six months ended November 30, 2003 and 2002
    4  
   
Consolidated Statements of Cash Flows for the Six months ended November 30, 2003 and 2002
    5  
   
Notes to Consolidated Financial Statements
    6-11  
 
Item 2—Management’s Discussion and Analysis of Financial Condition and Results of Operations
    11-18  
 
Item 3— Quantitative and Qualitative Disclosures About Market Risk
    18  
 
Item 4—Controls and Procedures
    18-19  
PART II – OTHER INFORMATION
       
 
Item 1— Legal Proceedings
    20  
 
Item 2—Changes in Securities and Use of Proceeds
    20  
 
Item 6— Exhibits and Reports on Form 8-K
    20  
 
Signatures
    21  
 
Certifications
    22-25  

2


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

      PART I. – FINANCIAL INFORMATION

      Item 1 – Consolidated Financial Statements

Consolidated Balance Sheets

                   
      November 30,   May 31,
      2003   2003
     
 
      (unaudited)        
      (Amounts in thousands)
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 2,796     $ 3,590  
 
Accounts receivable, less allowance for doubtful accounts of $27
    255       75  
 
Accounts receivable – managed care reinsurance contract
    482       354  
 
Other current assets
    368       605  
 
   
     
 
Total current assets
    3,901       4,624  
Property and equipment, net
    374       230  
Note receivable
    153       155  
Goodwill, net
    991       991  
Restricted cash
    327       328  
Other assets
    52       51  
 
   
     
 
Total assets
  $ 5,798     $ 6,379  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
               
Current liabilities:
               
 
Accounts payable and accrued liabilities
  $ 1,782     $ 1,836  
 
Accrued claims payable
    3,873       4,103  
 
Accrued reinsurance claims payable
    3,315       3,117  
 
Income taxes payable
    19       15  
 
   
     
 
Total current liabilities
    8,989       9,071  
 
   
     
 
Long-term liabilities:
               
 
Long-term debt
    2,244       2,244  
 
Other liabilities
    87       54  
 
   
     
 
Total long-term liabilities
    2,331       2,298  
 
   
     
 
Total liabilities
    11,320       11,369  
 
   
     
 
Commitments and Contingencies (Note 5)
               
Stockholders’ deficit:
               
 
Preferred stock, $50.00 par value; authorized 18,740 shares; none issued
           
 
Common stock, $0.01 par value; authorized 12,500,000 shares; issued and outstanding 3,943,049 and 3,936,549
    39       39  
 
Additional paid-in-capital
    51,941       51,928  
 
Deferred compensation
    (4 )     (16 )
 
Accumulated deficit
    (57,498 )     (56,941 )
 
   
     
 
Total stockholders’ deficit
    (5,522 )     (4,990 )
 
   
     
 
Total liabilities and stockholders’ deficit
  $ 5,798     $ 6,379  
 
   
     
 

See accompanying notes.

3


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Consolidated Statements of Operations
(Unaudited)
(Amounts in thousands, except per share amounts)

                                   
      Three months Ended   Six Months Ended
      November 30,   November 30,
     
 
      2003   2002   2003   2002
     
 
 
 
Operating revenues
  $ 7,011     $ 8,631     $ 14,904     $ 16,938  
Costs and expenses:
                               
 
Healthcare operating expenses
    6,199       7,760       13,051       15,113  
 
General and administrative expenses
    970       952       1,878       1,840  
 
Recovery of doubtful accounts
    (4 )     (6 )     (12 )     (14 )
 
Depreciation and amortization
    28       63       55       131  
 
   
     
     
     
 
 
    7,193       8,769       14,972       17,070  
 
   
     
     
     
 
Operating loss from continuing operations before items shown below
    (182 )     (138 )     (68 )     (132 )
Other income (expense):
                               
 
Gain on sale of assets
          1             4  
 
Loss on disposal of assets
                      (5 )
 
Interest income
    6       13       18       29  
 
Interest expense
    (54 )     (44 )     (102 )     (90 )
 
Other non-operating income
          478       1       478  
 
   
     
     
     
 
(Loss) income from continuing operations before income taxes
    (230 )     310       (151 )     284  
Income tax expense
    3       3       20       10  
 
   
     
     
     
 
(Loss) income from continuing operations
  $ (233 )   $ 307     $ (171 )   $ 274  
Loss from discontinued operations
                (387 )      
 
   
     
     
     
 
Net (loss) income attributable to common stockholders
  $ (233 )   $ 307     $ (558 )   $ 274  
 
   
     
     
     
 
(Loss) income per common share — basic:
                               
(Loss) income from continuing operations
  $ (0.06 )   $ 0.08     $ (0.04 )   $ 0.07  
Loss from discontinued operations
                (0.10 )      
 
   
     
     
     
 
Net (loss) income
  $ (0.06 )   $ 0.08     $ (0.14 )   $ 0.07  
 
   
     
     
     
 
(Loss) income per common share – diluted:
                               
(Loss) income from continuing operations
  $ (0.06 )   $ 0.07     $ (0.04 )   $ 0.07  
Loss from discontinued operations
                (0.10 )      
 
   
     
     
     
 
Net (loss) income
  $ (0.06 )   $ 0.07     $ (0.14 )   $ 0.07  
 
   
     
     
     
 
Weighted average common shares outstanding:
                               
Basic
    3,942       3,898       3,939       3,892  
 
   
     
     
     
 
Diluted
    3,942       4,254       3,939       3,984  
 
   
     
     
     
 

See accompanying notes.

4


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows
(Unaudited)

                   
      Six Months Ended
      November 30,
     
      2003   2002
     
 
      (Amounts in thousands)
Cash flows from operating activities:
               
Net (loss) income from continuing operations
  $ (171 )   $ 274  
Adjustments to reconcile net (loss) income from continuing operations to net cash used in operating activities:
               
 
Depreciation and amortization
    55       131  
 
Gain on sale of assets
          (4 )
 
Compensation expense – stock issued
    23       20  
 
Compensation expense – stock options issued
          1  
 
Other non-operating gain
          (470 )
 
Loss on disposal of assets
          5  
Changes in assets and liabilities:
               
 
Accounts receivable
    (180 )     (807 )
 
Accounts receivable — managed care reinsurance contract
    (128 )     (62 )
 
Other current assets, restricted funds, and other non-current assets
    145       21  
 
Accounts payable and accrued liabilities
    (345 )     (621 )
 
Accrued claims payable
    (230 )     (91 )
 
Accrued reinsurance claims payable
    198       542  
 
Income taxes payable
    4       (2 )
 
Other liabilities
    (1 )      
 
   
     
 
 
Net cash used in continuing operations
    (630 )     (1,063 )
 
Net cash used in discontinued operations
    (22 )      
 
   
     
 
 
Net cash used in continuing and discontinued operations
    (652 )     (1,063 )
 
   
     
 
Cash flows from investing activities:
               
 
Net proceeds from sale of property and equipment
          3  
 
Payments received on note receivable
    2       2  
 
Additions to property and equipment
    (132 )     (22 )
 
   
     
 
 
Net cash used in investing activities
    (130 )     (17 )
 
   
     
 
Cash flows from financing activities:
               
 
Proceeds from the issuance of Common Stock
    2        
 
Repayment of debt
    (14 )     (6 )
 
   
     
 
 
Net cash used in financing activities
    (12 )     (6 )
 
   
     
 
Net decrease in cash and cash equivalents
    (794 )     (1,086 )
Cash and cash equivalents at beginning of year
    3,590       5,340  
 
   
     
 
Cash and cash equivalents at end of period
  $ 2,796     $ 4,254  
 
   
     
 

See accompanying notes

5


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

Note 1 – Summary of Significant Accounting Policies

      The consolidated balance sheet as of November 30, 2003, and the related consolidated statements of operations for the three and six months ended November 30, 2003 and 2002, and cash flows for the six months ended November 30, 2003 and 2002 are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments necessary for a fair presentation of such financial statements have been included. Such adjustments consisted only of normal recurring items. The results of operations for the six months ended November 30, 2003 are not necessarily indicative of the results to be expected during the balance of the fiscal year.

      The consolidated financial statements do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. The balance sheet at May 31, 2003 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statement presentation. Notes to consolidated financial statements included in Form 10-K for the year ended May 31, 2003 are on file with the Securities and Exchange Commission and provide additional disclosures and a further description of accounting policies.

      The Company’s financial statements are presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recovery and classification of assets or the amount and classification of liabilities that may result from the outcome of the uncertainties described in Note 2 — “Basis of Presentation.”

      The Company’s managed care activities are performed under the terms of agreements with health maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”), and other health plans or payers to provide contracted behavioral healthcare services to subscribing participants. Revenue under a substantial portion of these agreements is earned monthly based on the number of qualified participants regardless of services actually provided (generally referred to as capitation arrangements). Such agreements accounted for 87.2%, or $13.0 million, of revenue for the six months ended November 30, 2003 and 88.0%, or $14.9 million, of revenue for the six months ended November 30, 2002. The balance of the Company’s revenues is earned on a fee-for-service basis and is recognized as services are rendered.

Restricted Cash

      As of November 30, 2003 and May 31, 2003, non-current restricted accounts include $0.3 million of cash held in trust in connection with the Company’s Directors and Officers liability insurance policy.

Accrued Claims Payable

      The accrued claims payable liability represents the estimated ultimate net amounts owed for all behavioral healthcare services provided through the respective balance sheet dates, including estimated amounts for claims incurred but not yet reported (“IBNR”) to the Company. The unpaid claims liability is estimated using an actuarial paid completion factor methodology and other statistical analyses and is continually reviewed and adjusted, if necessary, to reflect any change in the estimated liability. These estimates are subject to the effects of trends in utilization and other factors. However, actual claims incurred could differ from the estimated claims payable amount reported as of November 30, 2003. Although considerable variability is inherent in such estimates, management believes that the unpaid claims liability is adequate.

Income Taxes

      The Company calculates deferred taxes and related income tax expense using the liability method. This method determines deferred taxes by applying the current tax rate to net operating loss carryforwards and to the cumulative temporary differences between the recorded carrying amounts and the corresponding tax basis of assets and liabilities. A valuation allowance is established for deferred tax assets unless their realization is considered more

6


Table of Contents

COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

likely than not. The Company’s provision for income taxes is the sum of the change in the balance of deferred taxes between the beginning and the end of the period and income taxes currently payable or receivable.

Stock Options

      In December 2002, the Financial Accounting Standards Board issued Statements of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosure,” which amends the disclosure requirements of SFAS 123, “Accounting for Stock-Based Compensation” and provides alternative methods of transition for a voluntary change to the fair value method of accounting for stock-based employee compensation. As permitted by SFAS 148, the Company has elected to follow Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (APB 25) and related interpretations in accounting for its employee stock options. Under APB 25, in the event that the exercise price of the Company’s employee stock options is less than the market price of the underlying stock on the date of grant, compensation expense is recognized. No stock-based employee compensation cost is reflected in net (loss) income, as all options granted under the Company’s employee stock options plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net (loss) income and (loss) income per share if the Company had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation.

                                     
        Quarter   Quarter   Six Months   Six Months
        Ended   Ended   Ended   Ended
        11/30/03   11/30/02   11/30/03   11/30/02
       
 
 
 
Net (loss) income, as reported
  $ (233 )   $ 307     $ (558 )   $ 274  
Deduct:
                               
   
Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax Effects
    (110 )     (43 )     (110 )     (62 )
 
   
     
     
     
 
Pro forma net (loss) income
  $ (343 )   $ 264     $ (668 )   $ 212  
 
   
     
     
     
 
(Loss) income per common share:
                               
 
Basic – as reported
  $ (0.06 )   $ 0.08     $ (0.14 )   $ 0.07  
 
   
     
     
     
 
 
Diluted – as reported
  $ (0.06